Clinical Trial: Postsurgical Analgesia After Unilateral Bunionectomy

U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07858734) titled 'Postsurgical Analgesia After Unilateral Bunionectomy' on Sept. 23.

Brief Summary: The study is designed to evaluate the safety, efficacy, and pharmacokinetics (PK) of two doses of AMT-143 in participants after unilateral bunionectomy.

Study Start Date: Oct. 18

Study Type: INTERVENTIONAL

Condition: Bunionectomy Bunion

Intervention: DRUG: AMT-143

Group 1 will receive AMT-143 containing 354 mg ropivacaine.

DRUG: AMT-143

Group 2 will receive AMT-143 containing 707 mg ropivacaine.

OTHER: Saline (NaCl 0,9 %) (placebo)

Group 3 will receive 2.00 mL Placebo [sodium chloride (NaCl) 0.9%].

Recruitment Status: RECRUITING

Sponsor: Am...